Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 2
2018 1
2019 1
2020 8
2021 6
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
STEP-CD study: ustekinumab use in paediatric Crohn's disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN.
Pujol-Muncunill G, Navas-López VM, Ledder O, Cohen S, Lekar M, Turner D, Kolho KL, Levine A, Croft NM, Bronsky J, Shouval DS, Assa A, Harris R, Kiparissi F, Aloi M, Afzal NA, Tzivinikos C, Barrio J, Norden C, Vega MJB, Buderus S, de Valderrama AF, de Ridder L, García-Romero R, Medina E, Sánchez C, Velasco M, Vicente S, Wilson DC, Naik S, Hradsky O, Cococcioni L, Martin-de-Carpi J. Pujol-Muncunill G, et al. Eur J Pediatr. 2024 May 3. doi: 10.1007/s00431-024-05588-2. Online ahead of print. Eur J Pediatr. 2024. PMID: 38700692
Rare and severe adverse events in children with inflammatory bowel disease: analysis of data from the PIBD-SETQuality Safety Registry.
Klomberg RCW, Hellendoorn AE, Kemos P, Rizopoulos D, Ruemmele FM, Croft NM, de Ridder L; PIBD-SETQuality Safety Registry collaborators. Klomberg RCW, et al. Lancet Child Adolesc Health. 2024 Apr 29:S2352-4642(24)00078-6. doi: 10.1016/S2352-4642(24)00078-6. Online ahead of print. Lancet Child Adolesc Health. 2024. PMID: 38697175
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP.
Rubín de Célix C, Martín-de-Carpi J, Pujol-Muncunill G, Palomino LM, Velasco Rodríguez-Belvís M, Martín-Masot R, Navas-López VM, Ricart E, Casanova MJ, Rodríguez-Martínez A, Leo-Carnerero E, Alcaraz A, Mañosa M, Hernández V, Cobelas Cobelas MC, Sánchez C, Menchén L, Mesonero F, Barreiro-De Acosta M, Martinón-Torres N, Tejido Sandoval C, Rendo Vázquez A, Corsino P, Vicente R, Hernández-Camba A, Alberto Alonso JR, Alonso-Abreu I, Castro Millán AM, Peries Reverter L, Castro B, Fernández-Salgado E, Busto Cuiñas MM, Benítez JM, Madero L, Clemente F, Riestra S, Jiménez-Treviño S, Boscá-Watts M, Crehuá-Gaudiza E, Calvo Moya M, Huguet JM, Largo-Blanco EM, González Vives L, Plaza R, Guerra I, Barrio J, Escartín L, Alfambra E, Cruz N, Muñoz MC, Muñoz Pino MG, Van Domselaar M, Botella B, Monfort Miquel D, Rodríguez Grau MC, De La Mano A, Ber Y, Calvo Iñiguez M, Martínez-Pérez TJ, Chaparro M, Gisbert JP. Rubín de Célix C, et al. Among authors: pujol muncunill g. J Clin Med. 2023 Jul 21;12(14):4813. doi: 10.3390/jcm12144813. J Clin Med. 2023. PMID: 37510928 Free PMC article.
Efficacy of Crohn's disease exclusion diet in treatment -naïve children and children progressed on biological therapy: a retrospective chart review.
Jijón Andrade MC, Pujol Muncunill G, Lozano Ruf A, Álvarez Carnero L, Vila Miravet V, García Arenas D, Egea Castillo N, Martín de Carpi J. Jijón Andrade MC, et al. Among authors: pujol muncunill g. BMC Gastroenterol. 2023 Jun 29;23(1):225. doi: 10.1186/s12876-023-02857-6. BMC Gastroenterol. 2023. PMID: 37386458 Free PMC article.
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort.
Salvador-Martín S, Zapata-Cobo P, Velasco M, Palomino LM, Clemente S, Segarra O, Sánchez C, Tolín M, Moreno-Álvarez A, Fernández-Lorenzo A, Pérez-Moneo B, Loverdos I, Navas López VM, Millán A, Magallares L, Torres-Peral R, García-Romero R, Pujol-Muncunill G, Merino-Bohorquez V, Rodríguez A, Salcedo E, López-Cauce B, Marín-Jiménez I, Menchén L, Laserna-Mendieta E, Lucendo AJ, Sanjurjo-Sáez M, López-Fernández LA. Salvador-Martín S, et al. Among authors: pujol muncunill g. Int J Mol Sci. 2023 Jan 16;24(2):1797. doi: 10.3390/ijms24021797. Int J Mol Sci. 2023. PMID: 36675312 Free PMC article.
Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN.
Yerushalmy-Feler A, Pujol-Muncunill G, Martin-de-Carpi J, Kolho KL, Levine A, Olbjørn C, Granot M, Bramuzzo M, Rolandsdotter H, Mouratidou N, Hradsky O, Scarallo L, Matar M, Rimon RM, Rinawi F, Shalem T, Najajra H, de Meij T, Aloi M, Rodríguez-Belvís MV, Alvisi P, Schneider AM, van Rheenen P, Navas-López VM, Kiparissi F, Barrio J, Turner D, Cohen S. Yerushalmy-Feler A, et al. Among authors: pujol muncunill g. J Pediatr Gastroenterol Nutr. 2022 Dec 1;75(6):717-723. doi: 10.1097/MPG.0000000000003608. Epub 2022 Sep 8. J Pediatr Gastroenterol Nutr. 2022. PMID: 36084231
Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real-world patient mix.
Atia O, Pujol-Muncunill G, Navas-López VM, Orlanski-Meyer E, Ledder O, Lev-Tzion R, Focht G, Shteyer E, Stein R, Aloi M, Russell RK, Martin-de-Carpi J, Turner D. Atia O, et al. Among authors: pujol muncunill g. Aliment Pharmacol Ther. 2022 Sep;56(5):794-801. doi: 10.1111/apt.17092. Epub 2022 Jun 23. Aliment Pharmacol Ther. 2022. PMID: 35735987 Free PMC article.
Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study.
Garcia-Romero R, de Zabarte Fernandez JMM, Pujol-Muncunill G, Donat-Aliaga E, Segarra-Cantón O, Irastorza-Terradillos I, Medina-Benitez E, Ruiz-Hernández CJ, Carrillo-Palau M, Ros-Arnal I, Rodriguez-Martínez A, Escartin-Madurga L, Gutiérrez-Junquera C, Vicente-Santamaría S, Rodriguez-Belvis MV, Fernández-Fernández S, Alberto-Alonso JR, Montraveta M, Torres-Peral R, Navalon-Rubio M, Navas-López VM, de Carpi JM. Garcia-Romero R, et al. Among authors: pujol muncunill g. Eur J Pediatr. 2021 Sep;180(9):3039-3040. doi: 10.1007/s00431-021-04117-9. Eur J Pediatr. 2021. PMID: 34027626 Free article. No abstract available.
Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study.
Garcia-Romero R, Martinez de Zabarte Fernandez JM, Pujol-Muncunill G, Donat-Aliaga E, Segarra-Cantón O, Irastorza-Terradillos I, Medina-Benitez E, Ruiz-Hernández CJ, Carrillo-Palau M, Ros-Arnal I, Rodriguez-Martínez A, Escartin-Madurga L, Gutiérrez-Junquera C, Vicente-Santamaría S, Velasco Rodriguez-Belvis M, Fernández-Fernández S, Alberto-Alonso JR, Montraveta M, Torres-Peral R, Navalon-Rubio M, Navas-López VM, Martin de Carpi J. Garcia-Romero R, et al. Among authors: pujol muncunill g. Eur J Pediatr. 2021 Sep;180(9):3029-3038. doi: 10.1007/s00431-021-04063-6. Epub 2021 Apr 20. Eur J Pediatr. 2021. PMID: 33880650
Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease.
Salvador-Martín S, Kaczmarczyk B, Álvarez R, Navas-López VM, Gallego-Fernández C, Moreno-Álvarez A, Solar-Boga A, Sánchez C, Tolin M, Velasco M, Muñoz-Codoceo R, Rodriguez-Martinez A, Vayo CA, Bossacoma F, Pujol-Muncunill G, Fobelo MJ, Millán-Jiménez A, Magallares L, Martínez-Ojinaga E, Loverdos I, Eizaguirre FJ, Blanca-García JA, Clemente S, García-Romero R, Merino-Bohórquez V, González de Caldas R, Vázquez E, Dopazo A, Sanjurjo-Sáez M, López-Fernández LA. Salvador-Martín S, et al. Among authors: pujol muncunill g. Pharmaceutics. 2021 Jan 8;13(1):77. doi: 10.3390/pharmaceutics13010077. Pharmaceutics. 2021. PMID: 33429950 Free PMC article.
22 results